Families’ Experience of Pediatric Onset Multiple Sclerosis
نویسندگان
چکیده
منابع مشابه
Social cognition in pediatric-onset multiple sclerosis (MS).
BACKGROUND Pediatric-onset multiple sclerosis (MS) patients represent a subpopulation who are diagnosed during the course of development. Social cognitive deficits have recently been recognized in adults with MS. It is critical to identify whether these youngest patients with the disorder are also at risk. OBJECTIVE To determine whether pediatric-onset MS is associated with social cognitive d...
متن کاملMRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
Currently, it is unclear whether pediatric multiple sclerosis (PMS) is a pathoetiologically homogeneous disease phenotype due to clinical and epidemiological differences between early and late onset PMS (EOPMS and LOPMS). Consequently, the question was raised whether diagnostic guidelines need to be complemented by specific EOPMS markers. To search for such markers, we analyzed cerebral MRI ima...
متن کاملEarly onset multiple sclerosis
Objective: To evaluate the clinical course of MS in individuals with onset of MS before age 16. Methods: Patients with onset of MS before age 16 (n 116) with complete clinical information on the clinical course from the MS Clinic at The University of British Columbia (UBC) Site Hospital computerized database (MS-COSTAR) were included in this study. The data were compared to those from the Canad...
متن کاملManagement of pediatric multiple sclerosis
10.2217/14750708.5.5.641 © 2 An increasing number of children and adolescents with multiple sclerosis are being identified and treated with disease-modifying therapies. As more rapid diagnosis is made possible due to the heightened awareness of pediatric multiple sclerosis among the pediatric and neurological communities, and the availability of MRI, the number of pediatric multiple sclerosis p...
متن کاملMultiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.
BACKGROUND Currently available disease-modifying therapies (DMTs) are known to be only partially effective in adults with multiple sclerosis (MS). Little is known about pediatric patients with MS who experience refractory disease while receiving first-line DMTs. OBJECTIVE To assess the occurrence and management of refractory disease in a group of pediatric patients with MS treated with first-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Child & Adolescent Trauma
سال: 2019
ISSN: 1936-1521,1936-153X
DOI: 10.1007/s40653-018-0243-7